This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
1g | $500 | In Stock |
2g | $750 | In Stock |
5g | $1125 | In Stock |
Cat #: V37614 CAS #: 2349386-89-4 Purity ≥ 98%
Description: Molnupiravir (EIDD-2801; MK4482; prodrug-EIDD1931; MK-4482; trade name Lagevrio) is a novel, potent and orally bioavailable prodrug of the ribonucleoside analog EIDD-1931 with a broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as COVID-19, SARS-CoV-2, MERS-CoV, SARS-CoV.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 329.31 |
---|---|
Molecular Formula | C13H19N3O7 |
CAS No. | 2349386-89-4 |
SMILES Code | O[C@@H]([C@H]([C@H](N1C(N/C(C=C1)=N/O)=O)O2)O)[C@H]2COC(C(C)C)=O |
Synonyms | Molnupiravir; MK-4482; MK4482; MK 4482; EIDD-2801; EIDD 2801; EIDD2801; prodrug-EIDD-1931; prodrug-EIDD 1931; prodrug-EIDD1931. |
Protocol | In Vitro | Molnupiravir (50-500 mg/kg; p.o.; every 12 hours for 3 days) is robustly antiviral and able to prevent SARS-CoV replication and disease. |
---|---|---|
In Vivo | Molnupiravir (7 mg/kg; p.o.; twice daily for 3.5 days) significantly reduces shed virus load and duration of fever. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 3.0367 mL | 15.1833 mL | 30.3665 mL | 60.7330 mL |
5mM | 0.6073 mL | 3.0367 mL | 6.0733 mL | 12.1466 mL |
10mM | 0.3037 mL | 1.5183 mL | 3.0367 mL | 6.0733 mL |
20mM | 0.1518 mL | 0.7592 mL | 1.5183 mL | 3.0367 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.